Komori
Governance4568DAIICHI SANKYO COMPANY,LIMITEDPharmaceuticals

Notice of Partial Revisions to the Performance-Linked Share-Based Remuneration under the Medium-Term Management Plan for Directors and Other Officers

The existing medium-term plan performance-linked share compensation program will continue for fiscal 2026 through fiscal 2030 and will be expanded to include directors and executive officers who are foreign nationals or reside overseas. Disposal of treasury shares will be added as a method of acquiring shares, and the performance evaluation indicators will be revised.

Worth reading
50Recurring
Scored from 1 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
40
¥100 million (maximum trust-fund amount)
Wording
Conditional
How definitive the wording is.

Contents of this filing

Changes this time

The program will continue with fiscal 2026 through fiscal 2030 as the new eligible period. Directors and executive officers who are foreign nationals or reside overseas will be added to the eligible participants, and the disposal of treasury shares will be added as a method of acquiring shares. The performance achievement conditions will be changed to revenue, operating profit, ROE, relative TSR, research and development progress, and sustainability indicators.

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this timeThe program will continue with fiscal 2026 through fiscal 2030 as the new eligible period. Directors and executive officers who are foreign nationals or reside overseas will be added to the eligible participants, and the disposal of treasury shares will be added as a method of acquiring shares. The performance achievement conditions will be changed to revenue, operating profit, ROE, relative TSR, research and development progress, and sustainability indicators.
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

As the eligible period for fiscal 2021 through fiscal 2025 has ended, the program will continue with fiscal 2026 through fiscal 2030 as the new eligible period.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Partial Revisions to the Performance-Linked Share-Based Remuneration under the Medium-Term Management Plan for Directors and Other Officers | DAIICHI SANKYO COMPANY,LIMITED (4568) timely disclosure | Komori